| |
Univariate
|
Multivariate
|
|---|
| |
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
|---|
|
Tumor location
| | | | |
|
Upper urinary tract vs. Bladder
|
0.889 (0.650-1.216)
|
0.462
| | |
|
Age, years
|
1.022 (1.005-1.039)
|
0.010
|
1.027 (1.010-1.044)
|
0.002
|
|
Sex
| | | | |
|
Female vs. Male
|
0.980 (0.643-1.493)
|
0.926
| | |
|
Body mass index, kg/m2
|
0.921 (0.874-0.971)
|
0.002
|
0.965 (0.916-1.016)
|
0.177
|
|
ASA score
| | | | |
|
≥2 vs.1
|
0.978 (0.711-1.343)
|
0.889
| | |
|
Hydronephrosis
| | | | |
|
Present vs. Absent
|
1.672 (1.221-2.289)
|
0.001
|
1.409 (1.015-1.957)
|
0.041
|
|
Pathological T category
| | | | |
|
pT2 vs. ≤pT1
|
3.410 (1.919-6.058)
|
<0.001
|
2.707 (1.500-4.884)
|
0.001
|
|
≥pT3 vs. ≤pT1
|
7.115 (4.366-11.593)
|
<0.001
|
4.960 (2.943-8.359)
|
<0.001
|
|
Pathological N category
| | | | |
|
pNx vs. pN-
|
1.126 (0.784-1.619)
|
0.520
|
1.126 (0.760-1.669)
|
0.554
|
|
pN+ vs. pN-
|
3.580 (2.364-5.422)
|
<0.001
|
1.986 (1.282-3.074)
|
0.002
|
|
Tumor grade
| | | | |
|
III vs. ≤II
|
1.963 (1.432-2.689)
|
<0.001
|
1.105 (0.778-1.567)
|
0.578
|
|
LVI
| | | | |
|
Present vs. Absent
|
2.875 (2.098-3.938)
|
<0.001
|
1.663 (1.164-2.374)
|
0.005
|
|
Associated CIS
| | | | |
|
Present vs. Absent
|
0.971 (0.624-1.512)
|
0.898
| | |
|
Surgical margin
| | | | |
|
Positive vs. Negative
|
3.158 (1.930-5.166)
|
<0.001
|
1.483 (0.888-2.477)
|
0.132
|
- Abbreviations: HR = hazard ratio, CI = confidence interval, ASA = American Society of Anesthesiologists, LVI = Lymphovascular invasion, CIS = carcinoma in situ.
